Geratherm Medical AG

Ozelle has won a Gold Award at the German Innovation Award for its EHBT-50 Mini Lab Multi-Functional Analyzer, recognized in the Medical Technologies category. This system integrates hematology, biochemistry, immunoassay, and AI-powered morphology analysis, addressing the need for faster diagnostics in decentralized clinical settings. The EHBT-50 aims to simplify workflows and improve diagnostic capabilities while reducing reliance on specialized personnel.

prnewswire

02:00 ETOzelle Wins German Innovation Award Gold for Advancing the Fourth Generation of Hematology Analysis

CS精准医

HCWC

Restore Hyper Wellness has declared May as NAD+ Month, launching exclusive offers to promote awareness and accessibility of NAD+ therapy. With a significant rise in consumer interest, the initiative aims to educate the public on the benefits of NAD+, a coenzyme crucial for cellular energy and health. The month features three offers, including discounted NAD+ IM shots and membership perks, to encourage participation in wellness routines. Dr. Rachele Pojednic emphasizes the long-term benefits of NAD+ supplementation for overall health.

Healthy Choice Wellness

iShares US Healthcare Providers

iShares Global Healthcare

Alphabet

Alphabet - C

11:55 ETRestore Hyper Wellness Declares May NAD+ Month, Launching Exclusive Offers To Help Americans Recharge At The Cellular Level

BC Platforms has signed a Strategic Collaboration Agreement with AWS to enhance healthcare innovation and precision medicine. This partnership will leverage AWS technologies to improve BC Platforms' research environments, enabling global collaboration on real-world data and supporting the European Health Data Space (EHDS). The collaboration aims to accelerate the deployment of AI-powered analytical tools and provide secure, compliant data environments for healthcare organizations. BC Mosaic, BC Platforms' trusted research environment, will be available on AWS Marketplace, facilitating faster deployment and access to vital healthcare datasets.

Amazon

04:03 ETBC Platforms signs Strategic Collaboration Agreement with AWS to accelerate healthcare and life sciences innovation

003008

CS Analytical Laboratory has announced a major expansion of its Clifton, New Jersey facility, doubling its laboratory space to meet increasing client demands in the pharmaceutical, biotechnology, and medical device sectors. This expansion will enhance their capacity for innovative testing services, including raw materials testing and microbiological services, while also creating high-quality jobs. The facility is the only cGMP, FDA-registered contract laboratory dedicated to container testing, reinforcing its leadership in the industry.

Core Laboratories Luxembourg SA

KETOP

03:50 ETCS Analytical Announces Major Laboratory Expansion

XRAY

Smartee Denti-Technology showcased its latest clinical innovations in jaw repositioning at the 7th European Aligner Society Congress in Brussels, attended by over 1,000 participants. The event highlighted advancements in orthodontics, including AI-driven treatment planning and 3D printing. Key presentations included a novel clear aligner system for severe jaw misalignments and early intervention strategies for growing patients. Smartee is expanding its European infrastructure, with a new production facility in Madrid and a UK subsidiary to enhance local support for orthodontists.

Dentsply Sirona

16:17 ETSmartee präsentiert klinische Innovationen im Bereich der Unterkieferrepositionierung und stärkt seine Präsenz in Europa auf dem EAS-Kongress 2026

CMND

ICUI

Artisight has recently secured a deal with UChicago Medicine in Chicago to roll out its Smart Hospital Platform throughout various care settings. The agreement involves installing over 1,800 devices in patient rooms, post-anesthesia care units (PACUs), and operating rooms. Additionally, the platform will be introduced to a new 575,000-square-foot freestanding cancer care facility, set to launch in April 2027. UChicago Medicine, a top academic health system in the country, is known for its comprehensive approach to clinical care.

Unusual Whales

Clearmind Medicine

ICU Medical

Prime Medicine

ChinaAMC SSE Health Care ETF Initiating Fund

Founder Fubon CSI Medicine and Medical Device Innovation ETF

iShares US Pharma

Hwabao WP CSI Pharmaceuticals ETF

Penghua CSI HK Connect Health Care Composite ETF

ICBCCS SSE STAR Biology and Medicine ETF

VG Health

Health Care Select Sector SPDR

ALPS Medical Breakthrough

E Fund CSI 300 Health Care ETF

Ping An CSI Medicine and Medical Device Innovation ETF

Artisight Announces Agreement With UChicago Medicine to Deploy Smart Hospital Platform

Berlin Heals Holding AG announced positive results from its First-In-Human CMIC-III study, presented at the Heart Rhythm Society's Congress in Chicago. The study evaluated a novel, less invasive approach to implanting the cardiac microcurrent (CMIC) device, showing significant improvements in Left Ventricular Ejection Fraction (LVEF), 6 Minute Walk Test (6MWT), Quality of Life (QOL), and New York Heart Association (NYHA) class. The company is initiating Phase II of the study and launching the C-MIC-IV trial to expand patient access and gather critical data for FDA approval.

16:00 ETBerlin Heals Presents Positive Late Breaking Results from the CMIC-III First-In-Human Less Invasive Study

MIRA

miraDry, Inc. reported a 55% year-over-year growth in patient spend and a 43% increase in total treatments in Q1 2026, significantly outpacing the 4% growth of the broader aesthetic energy-based device market. This growth indicates strong patient demand, particularly among individuals over 35, who now make up nearly half of miraDry's patients. The company is launching Odor Awareness Week on April 20, 2026, featuring a webinar on odor science and patient trends. miraDry offers a non-surgical solution for excessive underarm sweat and odor, with over 500,000 patients treated globally.

Mira Pharmaceuticals

ChinaAMC CSI Biotechnology Theme ETF

Huatai-PB Hang Seng Innovative Drugs Industry ETF(QDII)

First Trust NYSE Arca Biotech Index Fd

Bosera Hang Seng SCHK Innovative Drug Select ETF

Minsheng Royal CSI Biotechnology Theme ETF

ChinaAMC Hang Seng Biotechnology Technology ETF(QDII)

China Merchants CSI Biotechnology Theme ETF

SPDR S&P Biotech

VanEck Biotech ETF

ChinaAMC SSE STAR Biology and Medicine ETF

Direxion S&P Biotech Bear 3X

Ark Genomic Revolution ETF

Invesco Biotechnology & Genome ETF

Bosera Hang Seng Health Care ETF(QDII)

Proshares Ultra Nasdaq Biotech

Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF

China Universal CNI HK Connect Innovative Drugs Industry ETF

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

iShares Biotechnology ETF

Direxion S&P Biotech Bull 3X

GF CSI HK Innovative Drugs Industry ETF(QDII)

15:50 ETmiraDry® Reports 55% Growth in Patient Spend, Significantly Outpacing Aesthetic Energy-Based Device Market, and Kicks Off Odor Awareness Week

Geratherm Medical AG(GME.DE)